“…Structurally, they consist of two aryl groups linked by an , -unsaturated ketone system (Ibrahim et al, 2012;Kumar et al, 2013), whereby the aryl groups can carry a variety of substituents such as hydroxyl, methoxy and alkenyl groups, which are by far the most commonly encountered ones in nature. With their structural simplicity and the associated ease of synthesis, chalcone compounds have attracted a considerable amount of attention because of their important pharmacological properties such as antioxidative (Aoki et al, 2008), anti-inflammatory (Israf et al, 2007), anti-gout (Jang et al, 2014), anti-histaminic (Yamamoto et al, 2004), anti-obesity (Birari et al, 2011), anti-protozoal (Chen et al, 1993), hypnotic (Cho et al, 2011) and anti-spasmodic (Sato et al, 2007) effects. In a continuation of our ongoing research on the properties of various chalcone derivatives (Sim et al, 2017, Kwong et al, 2018, we report herein the synthesis and crystal structure determination of the title compound, C 19 H 20 O 5 , (I).…”